Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Organovo Holdings, Inc. (ONVO : NSDQ)
 
 • Company Description   
Organovo Holdings, Inc. is a three-dimensional biology company focused on delivering breakthrough bioprinting technology and creating tissue on demand for research and medical applications. Its NovoGen 3D printing technology is a platform that works across various tissue and cell types. Organovo Holdings, Inc. is based in San Diego, California.

Number of Employees: 9

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.55 Daily Weekly Monthly
20 Day Moving Average: 28,030 shares
Shares Outstanding: 8.71 (millions)
Market Capitalization: $22.20 (millions)
Beta: 0.63
52 Week High: $11.25
52 Week Low: $2.24
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -22.73% -15.65%
12 Week -11.46% -4.31%
Year To Date -29.75% -16.79%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
11555 SORRENTO VALLEY ROAD SUITE 100
-
SAN DIEGO,CA 92121
USA
ph: 858-224-1000
fax: -
ir@organovo.com http://www.organovo.com
 
 • General Corporate Information   
Officers
Keith Murphy - Executive Chairman
Jonathan Lieber - Chief Financial Officer
Adam Stern - Director
Douglas Cohen - Director
David Gobel - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 68620A203
SIC: 2836
Fiscal Year
Fiscal Year End: March
Last Reported Quarter: 12/01/21
Next Expected EPS Date: 06/21/22
Share - Related Items
Shares Outstanding: 8.71
Most Recent Split Date: 8.00 (0.05:1)
Beta: 0.63
Market Capitalization: $22.20 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 06/21/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.71
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -8.11%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
03/31/22 - -
12/31/21 - -32.76
09/30/21 - -32.38
ROA
03/31/22 - -
12/31/21 - -31.19
09/30/21 - -31.38
Current Ratio
03/31/22 - -
12/31/21 - 15.54
09/30/21 - 20.48
Quick Ratio
03/31/22 - -
12/31/21 - 15.54
09/30/21 - 20.48
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Book Value
03/31/22 - -
12/31/21 - 3.59
09/30/21 - 3.93
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
Debt-to-Capital
03/31/22 - -
12/31/21 - 0.00
09/30/21 - 0.00
 

Powered by Zacks Investment Research ©